This Acne Awareness Month, SkinPen and PanOxyl are joining forces for a new campaign spotlighting a holistic approach to acne care. Together, the brands are showcasing how consumers can address both ...
Crown Laboratories, Inc., a privately held player in the skincare industry, agreed on Monday to acquire Revance Therapeutics, Inc. (NASDAQ:RVNC). Under the terms of the agreement, Crown will commence ...
After debuting in the aesthetics market with Daxxify last year, Revance has made its way to the potentially lucrative therapeutic space. With a Monday FDA nod to treat cervical dystonia in adults, ...
(RTTNews) - Revance Therapeutics, Inc. (RVNC) disclosed on Monday that it has entered into a merger agreement with Crown Laboratories, Inc., which plans to purchase all outstanding shares of Revance's ...
Revance Announces Publication of SAKURA 1 and SAKURA 2 Results in Plastic and Reconstructive Surgery
- Results show DaxibotulinumtoxinA for Injection (DAXI) can reduce frown lines for 24 weeks (approximately 6 months) or more - This manuscript presents the findings from SAKURA 1 and 2 side-by-side, ...
NASHVILLE, Tenn., March 25, 2026 /PRNewswire/ -- Revance, a fast-growing global aesthetics, regenerative and consumer skincare company, will showcase the latest innovations and new indications across ...
Shares of Revance Therapeutics surged 18% Thursday after the company announced the Food and Drug Administration had approved Daxxify, a facial injection drug that Revance hopes will challenge Botox’s ...
Revance Therapeutics has traveled a long road to a potential FDA approval for its Botox competitor, including COVID delays that pushed back plant inspections. Now, it faces a new obstacle: a patent ...
Milestone underscores rapid growth of microneedling and strong demand for SkinPen NASHVILLE, Tenn., March 31, 2026 /PRNewswire/ -- Revance, a fast-growing global aesthetics and skincare company, ...
Revance Therapeutics (RVNC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Stacy Ku from TD Cowen maintained a Buy rating on the stock and has ...
The MarketWatch News Department was not involved in the creation of this content. NASHVILLE, Tenn., March 25, 2026 /PRNewswire/ -- Revance, a fast-growing global aesthetics, regenerative and consumer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results